PUBLISHER: TechNavio | PRODUCT CODE: 2110138
PUBLISHER: TechNavio | PRODUCT CODE: 2110138
The global advanced therapy chain-of-custody software market is forecasted to grow by USD 127735.0 thousand during 2025-2030, accelerating at a CAGR of 18.1% during the forecast period. The report on the global advanced therapy chain-of-custody software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalation in commercialization of cell and gene therapy pipelines, stringent global regulatory compliance and quality assurance requirements, technological integration of blockchain and ai for enhanced transparency.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 17.2% |
| CAGR | 18.1% |
| Incremental Value | $127735.0 thousand |
Technavio's global advanced therapy chain-of-custody software market is segmented as below:
By Component
By End-User
By Type
Geography
This study identifies the proliferation of predictive analytics and ai in supply chain orchestration as one of the prime reasons driving the global advanced therapy chain-of-custody software market growth during the next few years. Also, transition toward cloud-native architectures and interoperable saas solutions and expansion of digital tracking capabilities to support point-of-care and decentralized manufacturing models will lead to sizable demand in the market.
The report on the global advanced therapy chain-of-custody software market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global advanced therapy chain-of-custody software market vendors that include Accenture Plc, Autolomous Ltd, Bio-IT World, Clarkston Consulting, CloudLIMS.com, Cryoport Systems LLC, Dassault Systemes SE, IDBS Ltd, Korber Pharma GmbH, MasterControl Solutions Inc., NMDP BioTherapies, Persistent Systems Ltd., Rockwell Automation Inc., Salesforce Inc., SAP SE, Siemens AG, Tenthpin Management Consultant, Title21 Health Solutions, TraceLink Inc., TrakCel. Also, the global advanced therapy chain-of-custody software market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.